217 related articles for article (PubMed ID: 2862515)
21. [Natural history of the state of asymptomatic carrier of HBsAg: 7-year follow-up].
Antoniozzi F; Meucci G; Vecchi M; Ronchi G; Collatina R; Del Ninno E; de Franchis R
Boll Ist Sieroter Milan; 1986; 65(5):347-53. PubMed ID: 3828089
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B antigens and antibodies in asymptomatic carriers and in chronic liver diseases.
Nakamura S; Takezawa Y; Sato T; Maeda T; Nakamura M; Kera K
Tohoku J Exp Med; 1979 May; 128(1):81-7. PubMed ID: 452007
[TBL] [Abstract][Full Text] [Related]
23. IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis.
Lavarini C; Farci P; Chiaberge E; Veglio V; Giacobbi D; Bedarida G; Susani G; Toti M; Almi P; Caporaso N
Br Med J (Clin Res Ed); 1983 Oct; 287(6401):1254-6. PubMed ID: 6416354
[TBL] [Abstract][Full Text] [Related]
24. [Antigens and antibodies in acute viral hepatitis caused by the B virus. Clinical significance].
Malacco E; Iacono G; Risso F
Minerva Med; 1979 Feb; 70(6):479-82. PubMed ID: 431867
[TBL] [Abstract][Full Text] [Related]
25. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
Gessoni G; Manoni F
Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
[TBL] [Abstract][Full Text] [Related]
26. [Detection of HBsAg and the related antibody (HBsAb) with the radioimmunological method. Behavior of the HBeAg-HBcAb system in HBsAg-positive patients].
Ortona L; Pizzigallo E; Federico G; Camilli G
Arch Sci Med (Torino); 1979; 136(4):509-22. PubMed ID: 550751
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B virus DNA in chronic HBsAg carriers: correlation with HBeAg/anti-HBe status, anti-HD and liver histology.
Stroffolini T; Sagnelli E; Rapicetta M; Felaco FM; Filippini P; Annella T; Petruzziello A; Chionne P; Sarrecchia B; Piccinino F
Hepatogastroenterology; 1992 Feb; 39(1):62-5. PubMed ID: 1568710
[TBL] [Abstract][Full Text] [Related]
28. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus.
Farci P; Gerin JL; Aragona M; Lindsey I; Crivelli O; Balestrieri A; Smedile A; Thomas HC; Rizzetto M
JAMA; 1986 Mar; 255(11):1443-6. PubMed ID: 3951078
[TBL] [Abstract][Full Text] [Related]
30. Experimental HBV and delta infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and delta antigen.
Rizzetto M; Canese MG; Purcell RH; London WT; Sly LD; Gerin JL
Hepatology; 1981; 1(6):567-74. PubMed ID: 7030907
[TBL] [Abstract][Full Text] [Related]
31. Infection with delta agent in Sweden: introduction of a new hepatitis agent.
Hansson BG; Moestrup T; Widell A; Nordenfelt E
J Infect Dis; 1982 Oct; 146(4):472-8. PubMed ID: 7119477
[TBL] [Abstract][Full Text] [Related]
32. The relationship of hepatitis B e antigen, DNA polymerase activity, and titer of hepatitis B surface antigen with ongoing liver injury in chronic hepatitis B virus infection.
Perrillo R; Campbell C; Wellinghoff W; Gelb L
Am J Gastroenterol; 1982 Jul; 77(7):445-9. PubMed ID: 7091131
[TBL] [Abstract][Full Text] [Related]
33. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
34. Fulminant delta hepatitis in chronic asymptomatic HBsAg carriers.
Tassopoulos N; Roumeliotou-Karayannis A; Nakopoulou L; Calafatas P; Papaevangelou G
JAMA; 1985 Apr; 253(16):2362-3. PubMed ID: 3981762
[No Abstract] [Full Text] [Related]
35. [Frequency of delta infections in Heidelberg].
Gmelin K; Theilmann L; Roggendorf M; Wolf P; Schlipköter U; Czygan P; Kommerell B; Deinhardt F
Klin Wochenschr; 1985 Feb; 63(4):164-7. PubMed ID: 3884893
[TBL] [Abstract][Full Text] [Related]
36. Infection with the delta agent in children.
Farci P; Barbera C; Navone C; Bortolotti F; Vajro P; Caporaso N; Vegnente A; Ansaldi N; Rizzetto M; Tolentino P
Gut; 1985 Jan; 26(1):4-7. PubMed ID: 3965366
[TBL] [Abstract][Full Text] [Related]
37. The significance of serologic, histologic, and immunohistologic findings in the prognosis of 88 asymptomatic carriers of hepatitis B surface antigen.
Dormeyer HH; Arnold W; Schönborn H; Braun B; Klinge O; Pfeifer U; Knolle J; Hess G; Kryger P; Nielsen JO; Meyer zum Büschenfelde KH
J Infect Dis; 1981 Jul; 144(1):33-7. PubMed ID: 7264370
[TBL] [Abstract][Full Text] [Related]
38. [Delta virus superinfection in a patient with chronic viral hepatitis B].
Decker T; Baumgarten R; Roschlau G
Zentralbl Allg Pathol; 1986; 132(4):283-8. PubMed ID: 3541449
[TBL] [Abstract][Full Text] [Related]
39. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
[TBL] [Abstract][Full Text] [Related]
40. [Relation of hepatitis B virus markers in the serum and hepatic tissue in chronic carriers of HBsAg].
Ferraz ML; Lanzoni VP; Silva AE; Alberti VN; Pereira CA; Chiferi Júnior V; Guimarães RX
AMB Rev Assoc Med Bras; 1989; 35(2):63-6. PubMed ID: 2695985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
